Induction of Labor Affected Fetus / Newborn Clinical Trial
— COMFORTOfficial title:
Cervical Ripening as an Outpatient Method Using the Foley: a Randomized Trial
NCT number | NCT05759988 |
Other study ID # | 851906 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 13, 2023 |
Est. completion date | June 30, 2027 |
A multicenter pragmatic randomized trial of nulliparous women undergoing a term (≥37 weeks) induction of labor wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing outpatient cervical ripening with a Foley catheter to routine inpatient cervical ripening (Foley +/- other method). With this trial, the investigators aim to test our central hypothesis that outpatient Foley will decrease the primary Cesarean Delivery (CD) rate and risk of maternal/neonatal morbidity compared with inpatient cervical ripening.
Status | Recruiting |
Enrollment | 2300 |
Est. completion date | June 30, 2027 |
Est. primary completion date | June 30, 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria - Eligible for induction of labor - Live singleton gestation =37 weeks and <42 weeks - Nulliparous, =18 years of age with no previous deliveries >20 weeks - Cephalic presentation - Intact membranes - Bishop score =8 and cervical dilation <3 cm - English or Spanish speaking (Able to read/understand consent and instructions) - Have reliable transportation to get back to the hospital and have a self-reported safe residence to go home to with the Foley catheter Exclusion Criteria - Known oligohydramnios (DVP <2cm) - Known moderate-severe polyhydramnios (AFI =30 at time of delivery) - Concern regarding fetal status during antenatal testing: At provider discretion, but includes fetal decelerations, biophysical profile =6/10 - Vaginal bleeding or concern for/known abruption prior to Foley placement - Chorioamnionitis - Any fetal growth restriction - Preeclampsia with severe features - Severe chronic hypertension - Type 1 diabetes or poorly controlled pre-gestational diabetes - Sickle cell disease - Major fetal anomaly - Women on therapeutic anticoagulation - Decreased fetal movement - HIV Positive (rationale: HIV positive patients require an IV medication at the start of labor induction which cannot be given as an outpatient. There is universal testing of HIV in the 3rd trimester to verify this exclusion criteria) - Maternal cardiac disease requiring telemetry monitoring throughout induction/labor course |
Country | Name | City | State |
---|---|---|---|
United States | University of Texas at Austin | Austin | Texas |
United States | Christiana Care Health Services, Inc. | Newark | Delaware |
United States | University of Pennsylvania | Philadelphia | Pennsylvania |
United States | University of Utah | Salt Lake City | Utah |
Lead Sponsor | Collaborator |
---|---|
University of Pennsylvania |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Heterogeneity of Treatment Effect/prespecified sub-groups | Pre-specified subgroups to be included are: Starting cervical dilation (<1cm vs. >=1cm), Bishop score (<6 vs. >=6), BMI (<30 kg/m2 vs. >=30 kg/m2), Race/ethnicity (Black, White, Asian, Other; Hispanic/Non-Hispanic), Gestational age at start of induction (37-39w6d vs. >=40 weeks), Advanced Maternal Age (AMA) (>=35 yo) vs not AMA (<35 yo) | within 6 weeks of delivery | |
Primary | Incidence of Cesarean Delivery | Incidence of cesarean delivery in women randomized to outpatient cervical ripening with the Foley catheter compared to women undergoing routine inpatient cervical ripening | At delivery | |
Secondary | Maternal morbidity incidence | Defined as a composite endpoint consisting of at least one occurrence of the following outcomes: postpartum hemorrhage, blood transfusion, endometritis, wound/laceration breakdown or infection, venous thromboembolis and hospital readmission with 6 weeks | Within 6 weeks of delivery | |
Secondary | Maternal patient satisfaction as measured by the Hollins Martin Birth Satisfaction scale-Revised (BSS-R) | Patient satisfaction as measured by the BSS-R with a possible score of 0-40 with 0 equaling the least birth satisfaction | From time of delivery to discharge from hospital, up to 6 weeks from delivery | |
Secondary | Neonatal morbidity incidence | Defined as a composite endpoint consisting of at least one incidence of the following outcomes: acidemia, respiratory failure/insufficiency, hypoxic-ischemic encephalopathy, treatment for hypoglycemia or suspected sepsis | Within 6 weeks of delivery | |
Secondary | Maternal patient perception of control | Measured by the Labour Agentry Scale (LAS), as 29-item questionnaire with higher values reflecting a higher measure of perceived personal control | From time of delivery to discharge from hospital, up to 6 weeks from delivery | |
Secondary | Maternal overall length of stay | Measured by hours from admission to postpartum discharge | From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery | |
Secondary | Maternal postpartum length of stay | Measured by hours from delivery to postpartum discharge | From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery | |
Secondary | Neonatal length of stay | Length of stay from birth to discharge, measured in hours | From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery | |
Secondary | NICU admission | Admission to neonatal intensive care unit | From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery | |
Secondary | NICU stay greater than 48 hours | Admission to the NICU for more than 48 hours | From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery | |
Secondary | Perceived stress scale-10 questions | A validated 10 question scale evaluating perceived stress | From time of delivery to discharge from hospital, up to 6 weeks from delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04492150 -
Effect of Glucose 5% on Labor Length
|
N/A | |
Not yet recruiting |
NCT03625518 -
Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes
|
Early Phase 1 | |
Completed |
NCT04496908 -
Early Versus Delayed Artificial Rupture of Membranes (AROM Trial)
|
Early Phase 1 | |
Recruiting |
NCT04478942 -
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
|
Early Phase 1 | |
Completed |
NCT04597333 -
Labor Induction After Failed Induction With Dinoprostone.
|
N/A | |
Completed |
NCT03682718 -
Vaginal Misoprostol With Intracervical Foley Catheter in Induction of Labor
|
Phase 4 | |
Recruiting |
NCT03533699 -
A Comparison Between the Effect of Oxytocin Only and Oxytocin Plus Propranolol on Induction of Labor in Term Pregnancy
|
N/A | |
Recruiting |
NCT05187247 -
VR Glasses During Induction of Labour for Pain and Anxiety Relieve
|
N/A | |
Active, not recruiting |
NCT02975167 -
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
|
N/A | |
Recruiting |
NCT05079841 -
The Stimulation To Induce Mothers Study
|
Phase 4 | |
Not yet recruiting |
NCT06375746 -
The Impact of a Customized Informative Video Prior to Induction of Labor on Anxiety Relieve - a Randomized Controlled Trial
|
Phase 3 | |
Completed |
NCT03822052 -
The Use of D5LR Versus LR for Induction of Labor and Time to Delivery in Multiparous and Primiparous Patient's With Favorable and Unfavorable Bishop's Scores
|
N/A | |
Completed |
NCT04220320 -
The Success of Labor Induction Based on a Modified BISHOP Score.
|
||
Withdrawn |
NCT04739683 -
Cervical Ripening With Foley Bulb Versus Dilapan-S at Home
|
N/A | |
Completed |
NCT03086967 -
Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours
|
N/A | |
Completed |
NCT04299854 -
Modality of Induction of Labor in Obese Women at Term (MODOBAT)
|
||
Completed |
NCT03944187 -
Sonographic Assessment for Prediction of Labor Induction Success
|
||
Recruiting |
NCT03928899 -
The Best Timing of Delivery in Women With GDM Study
|
N/A | |
Not yet recruiting |
NCT04350437 -
Induction Of Labor: Predictors of Outcomes
|
N/A | |
Terminated |
NCT04011098 -
Improving Labour Induction Analgesia: Epidural Fentanyl Bolus at Epidural Initiation for Induction of Labour
|
Phase 1 |